# Zgc Shuimu Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zgc-shuimu-medical

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.zgcsm.cn
- Total disclosed funding: $15M
- Latest round: Series B (Sep 5, 2025)
- Investors on record: 12

## About

Based in Beijing, China, and established in 2017, Zgc Shuimu Medical is a medical technology company that provides medical device inspection and testing services. In November 2020, it obtained the qualification of Inspection and Testing Institution (National CMA certification) and National Accreditation Service for Conformity Assessment (CNAS) certificate. In September 2025, Zgc Shuimu Medical closed a series B funding co-led by new investors Hony Capital and Guangzhou Guoju Venture Capital, with participation from new investors BIO-TOWN Capital and Guangzhou Industry Investment Holding Group.
 
The company's business can be categorized into active medical devices and in-vitro diagnostic reagents. It has medical device electromagnetic compatibility testing platforms, electrical safety testing platforms, reliability testing platforms, packaging testing platforms, software testing platforms, and IVD testing platforms. The company has passed a total of 1012 items accreditation of inspection and testing standards that covers more than 90% of active medical devices and in vitro diagnostic (IVD) testing items.
The company will expand the integrated medical device service platform and strengthen the development of a nationwide service network.

## Funding rounds

- Series B, Sep 5, 2025 — Hony Capital, Guangzhou Guoju Venture Capital, Guangzhou Industry Investment Holding Group, BIO-TOWN Capital
- Series A, Jul 22, 2022 — Green Pine Capital Partners, Yijing Investment
- Series A, Aug 25, 2021, $15M — YuanBio Venture, MED-FINE Capital
- Angel, Jan 7, 2019 — Zhongguancun Venture Capital, C. Domain, Beijing Capital Science and Technology Development Group Investment Management, Shuimu Dongfang Medical Robot

## Investors

- Zhongguancun Venture Capital (https://capitalatlas.ai/funds/zhongguancun-venture-capital) — Angel
- C. Domain (https://capitalatlas.ai/funds/c-domain) — Angel
- Beijing Capital Science and Technology Development Group Investment Management (https://capitalatlas.ai/funds/beijing-capital-science-and-technology-development-group-inv) — Angel
- Shuimu Dongfang Medical Robot — Angel
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A
- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series A
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series A
- Yijing Investment (https://capitalatlas.ai/funds/yijing-investment) — Series A
- Hony Capital (https://capitalatlas.ai/funds/hony-capital) — Series B
- Guangzhou Guoju Venture Capital (https://capitalatlas.ai/funds/guangzhou-guoju-venture-capital) — Series B
- Guangzhou Industry Investment Holding Group (https://capitalatlas.ai/funds/guangzhou-industry-investment-holding-group) — Series B
- BIO-TOWN Capital (https://capitalatlas.ai/funds/bio-town-capital) — Series B